The report, created by QuintilesIMS Institute for the Generic Pharmaceutical Association, compares the total savings — including Medicare, Medicaid, commercial payer and uninsured cash saving — of all 50 states.
Here is a list of states ranked by total generic drug savings. Ties are represented with an asterisk.
1. California — $20.1 billion
2. New York — $19.2 billion
3. Texas — $16 billion
4. Florida — $13 billion
5. Pennsylvania — $10.5 billion
6. Ohio — $9.6 billion
7. Illinois — $8.9 billion
8. North Carolina — $7.5 billion
9. Michigan — $7.4 billion
10. Georgia — $7.2 billion
11. New Jersey — $6.1 billion
12. Tennessee — $6 billion
13. Virginia — $5.4 billion
14.Massachusetts — $5.2 billion
15. Indiana — $5 billion
16. Kentucky — $4.7 billion
*Missouri — $4.7 billion
17. Alabama — $4.5 billion
18. Louisiana — $4.3 billion
19. Arizona — $4 billion
20. Washington — $3.8 billion
*Wisconsin — $3.8 billion
21. Maryland — $3.7 billion
*South Carolina — $3.7 billion
22. Minnesota — $3.3 billion
23. Arkansas — $2.8 billion
24. Mississippi — $2.7 billion
*Oklahoma — $2.7 billion
25. Colorado — $2.6 billion
*Connecticut — $2.6 billion
26. Iowa — $2.5 billion
27. Kansas — $2.3 billion
*Oregon — $2.3 billion
28. West Virginia — $2.1 billion
29. Utah — $1.7 billion
30. Nevada — $1.6 billion
31. Nebraska — $1.5 billion
32. New Mexico — $1.1 billion
33. Rhode Island — $1 billion
34. Maine — $954 million
35. Idaho — $943 million
36. New Hampshire — $848 million
37. Hawaii — $721 million
38. Delaware — $659 million
39. North Dakota — $626 million
40. Montana — $602 million
41. South Dakota — $583 million
42. Vermont — $337 million
43. Wyoming — $312 million
44. Alaska — $294 million
More articles on supply chain:
4 latest FDA approvals
‘Project Toto’: CVS Health to open large distribution center in Kansas
FDA funds $23M in grants to spur rare disease drug research